Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 237

    1.

    Long-term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitis.

    Bangarulingam SY, Bjornsson E, Enders F, Barr Fritcher EG, Gores G, Halling KC, Lindor KD.

    Hepatology. 2009 Sep 9. [Epub ahead of print]PMID: 19877179 [PubMed - as supplied by publisher]Related articles

    2.

    Betaine for nonalcoholic fatty liver disease: Results of a randomized placebo-controlled trial.

    Abdelmalek MF, Sanderson SO, Angulo P, Soldevila-Pico C, Liu C, Peter J, Keach J, Cave M, Chen T, McClain CJ, Lindor KD.

    Hepatology. 2009 Dec;50(6):1818-26.PMID: 19824078 [PubMed - in process]Related articles

    3.

    Antibiotics for the Treatment of Primary Sclerosing Cholangitis.

    Elfaki DA, Lindor KD.

    Am J Ther. 2009 Sep 15. [Epub ahead of print]PMID: 19770792 [PubMed - as supplied by publisher]Related articles

    4.

    Review article: nuclear receptors and liver disease--current understanding and new therapeutic implications.

    Elfaki DA, Bjornsson E, Lindor KD.

    Aliment Pharmacol Ther. 2009 Oct 15;30(8):816-25. Epub 2008 Jul 23.PMID: 19706148 [PubMed - in process]Related articles

    5.

    Cholangiocarcinoma in primary sclerosing cholangitis.

    Abbas G, Lindor KD.

    J Gastrointest Cancer. 2009;40(1-2):19-25. Epub 2009 Aug 25.PMID: 19705300 [PubMed - in process]Related articles

    6.

    High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis.

    Lindor KD, Kowdley KV, Luketic VA, Harrison ME, McCashland T, Befeler AS, Harnois D, Jorgensen R, Petz J, Keach J, Mooney J, Sargeant C, Braaten J, Bernard T, King D, Miceli E, Schmoll J, Hoskin T, Thapa P, Enders F.

    Hepatology. 2009 Sep;50(3):808-14.PMID: 19585548 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Primary biliary cirrhosis.

    Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ; American Association for Study of Liver Diseases.

    Hepatology. 2009 Jul;50(1):291-308. No abstract available. PMID: 19554543 [PubMed - indexed for MEDLINE]Related articles

    8.

    38-year-old woman with abnormal liver enzymes and hyperlipidemia.

    Silveira MG, Lindor KD.

    Mayo Clin Proc. 2009 Jun;84(6):551-4. No abstract available. PMID: 19483172 [PubMed - indexed for MEDLINE]Related articles

    9.

    Thyroid dysfunction in primary biliary cirrhosis, primary sclerosing cholangitis and non-alcoholic fatty liver disease.

    Silveira MG, Mendes FD, Diehl NN, Enders FT, Lindor KD.

    Liver Int. 2009 Aug;29(7):1094-100. Epub 2009 Mar 12.PMID: 19291181 [PubMed - indexed for MEDLINE]Related articles

    10.

    Complications of endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis.

    Bangarulingam SY, Gossard AA, Petersen BT, Ott BJ, Lindor KD.

    Am J Gastroenterol. 2009 Apr;104(4):855-60. Epub 2009 Mar 3.PMID: 19259076 [PubMed - indexed for MEDLINE]Related articles

    11.

    Moexipril for Treatment of Primary Biliary Cirrhosis in Patients with an Incomplete Response to Ursodeoxycholic Acid.

    Charatcharoenwitthaya P, Talwalkar JA, Angulo P, Gossard AA, Keach JC, Petz JL, Jorgensen RA, Lindor KD.

    Dig Dis Sci. 2009 Mar 3. [Epub ahead of print]PMID: 19255851 [PubMed - as supplied by publisher]Related articles

    12.

    A new section: image of the month.

    Lindor KD.

    Hepatology. 2009 Feb;49(2):344. No abstract available. PMID: 19177489 [PubMed - indexed for MEDLINE]Related articles

    13.

    Cholangiocarcinoma: expanding the spectrum of risk factors.

    Elfaki DH, Gossard AA, Lindor KD.

    J Gastrointest Cancer. 2008;39(1-4):114-7. Epub 2009 Jan 14.PMID: 19142590 [PubMed - indexed for MEDLINE]Related articles

    14.

    A patient with primary biliary cirrhosis and elevated LDL cholesterol.

    Foley KF, Silveira MG, Hornseth JM, Lindor KD, McConnell JP.

    Clin Chem. 2009 Jan;55(1):187-91; disscusion 191-2. No abstract available. PMID: 19106186 [PubMed - indexed for MEDLINE]Related articles

    15.

    Minocycline in the treatment of patients with primary sclerosing cholangitis: results of a pilot study.

    Silveira MG, Torok NJ, Gossard AA, Keach JC, Jorgensen RA, Petz JL, Lindor KD.

    Am J Gastroenterol. 2009 Jan;104(1):83-8.PMID: 19098854 [PubMed - indexed for MEDLINE]Related articles

    16.

    Overlap syndromes with autoimmune hepatitis in chronic cholestatic liver diseases.

    Silveira MG, Lindor KD.

    Expert Rev Gastroenterol Hepatol. 2007 Dec;1(2):329-40. Review.PMID: 19072425 [PubMed - indexed for MEDLINE]Related articles

    17.

    Research productivity of graduates from 3 physician-scientist training programs.

    Dyrbye LN, Lindor KD, LaRusso NF, Cook DA.

    Am J Med. 2008 Dec;121(12):1107-13. No abstract available. PMID: 19028208 [PubMed - indexed for MEDLINE]Related articles

    18.

    Dr. H. Butt tribute.

    Lindor KD.

    Hepatology. 2008 Oct;48(4):1027. No abstract available. PMID: 18821594 [PubMed - indexed for MEDLINE]Related articles

    19.

    Surveillance for hepatocellular carcinoma in patients with primary biliary cirrhosis.

    Silveira MG, Suzuki A, Lindor KD.

    Hepatology. 2008 Oct;48(4):1149-56.PMID: 18785621 [PubMed - indexed for MEDLINE]Related articles

    20.

    Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis.

    Charatcharoenwitthaya P, Enders FB, Halling KC, Lindor KD.

    Hepatology. 2008 Oct;48(4):1106-17.PMID: 18785620 [PubMed - indexed for MEDLINE]Related articles

    21.

    Primary sclerosing cholangitis.

    Silveira MG, Lindor KD.

    Can J Gastroenterol. 2008 Aug;22(8):689-98. Review.PMID: 18701947 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Clinical Trial: Randomized controlled trial of zidovudine and lamivudine for patients with primary biliary cirrhosis stabilized on ursodiol.

    Mason AL, Lindor KD, Bacon BR, Vincent C, Neuberger JM, Wasilenko ST.

    Aliment Pharmacol Ther. 2008 Jul 9. [Epub ahead of print]PMID: 18627363 [PubMed - as supplied by publisher]Related articles

    23.

    Clinical features and management of primary sclerosing cholangitis.

    Silveira MG, Lindor KD.

    World J Gastroenterol. 2008 Jun 7;14(21):3338-49. Review.PMID: 18528931 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Antimitochondrial antibody-negative primary biliary cirrhosis.

    Mendes F, Lindor KD.

    Gastroenterol Clin North Am. 2008 Jun;37(2):479-84, viii. Review.PMID: 18499032 [PubMed - indexed for MEDLINE]Related articles

    25.

    Treatment of primary biliary cirrhosis: therapy with choleretic and immunosuppressive agents.

    Silveira MG, Lindor KD.

    Clin Liver Dis. 2008 May;12(2):425-43; x-xi. Review.PMID: 18456189 [PubMed - indexed for MEDLINE]Related articles

    26.

    High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis.

    Silveira MG, Lindor KD.

    J Hepatol. 2008 May;48(5):692-4. Epub 2008 Feb 14. No abstract available. PMID: 18336948 [PubMed - indexed for MEDLINE]Related articles

    27.

    Mortality attributable to cholestatic liver disease in the United States.

    Mendes FD, Kim WR, Pedersen R, Therneau T, Lindor KD.

    Hepatology. 2008 Apr;47(4):1241-7.PMID: 18318437 [PubMed - indexed for MEDLINE]Related articles

    28.

    Utility of liver biopsy in bone marrow transplant patients.

    Chahal P, Levy C, Litzow MR, Lindor KD.

    J Gastroenterol Hepatol. 2008 Feb;23(2):222-5.PMID: 18289356 [PubMed - indexed for MEDLINE]Related articles

    29.

    Recurrence of primary sclerosing cholangitis: what do we learn from several transplant centers?

    Charatcharoenwitthaya P, Lindor KD.

    Liver Transpl. 2008 Feb;14(2):130-2. No abstract available. PMID: 18236444 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Quality of life and everyday activities in patients with primary biliary cirrhosis.

    Selmi C, Gershwin ME, Lindor KD, Worman HJ, Gold EB, Watnik M, Utts J, Invernizzi P, Kaplan MM, Vierling JM, Bowlus CL, Silveira MG, Bossi I; USA PBC Epidemiology Group.

    Hepatology. 2007 Dec;46(6):1836-43.PMID: 18027862 [PubMed - indexed for MEDLINE]Related articles

    31.

    Impact of inflammatory bowel disease and ursodeoxycholic acid therapy on small-duct primary sclerosing cholangitis.

    Charatcharoenwitthaya P, Angulo P, Enders FB, Lindor KD.

    Hepatology. 2008 Jan;47(1):133-42.PMID: 17992695 [PubMed - indexed for MEDLINE]Related articles

    32.

    Putting the needs of the patient first: Mayo Clinic's core value, institutional culture, and professionalism covenant.

    Viggiano TR, Pawlina W, Lindor KD, Olsen KD, Cortese DA.

    Acad Med. 2007 Nov;82(11):1089-93.PMID: 17971697 [PubMed - indexed for MEDLINE]Related articles

    33.

    Primary sclerosing cholangitis--approach to diagnosis.

    Steele IL, Levy C, Lindor KD.

    MedGenMed. 2007 Apr 25;9(2):20. Review. No abstract available. PMID: 17955076 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Silymarin in the treatment of patients with primary sclerosing cholangitis: an open-label pilot study.

    Angulo P, Jorgensen RA, Kowdley KV, Lindor KD.

    Dig Dis Sci. 2008 Jun;53(6):1716-20.PMID: 17940903 [PubMed - indexed for MEDLINE]Related articles

    35.

    Characteristics of primary sclerosing cholangitis in the USA.

    Lindor KD.

    Hepatol Res. 2007 Oct;37 Suppl 3:S474-7.PMID: 17931206 [PubMed - in process]Related articles

    36.

    Development of autoimmune hepatitis in primary biliary cirrhosis.

    Gossard AA, Lindor KD.

    Liver Int. 2007 Oct;27(8):1086-90.PMID: 17845536 [PubMed - indexed for MEDLINE]Related articles

    37.

    Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation.

    Charatcharoenwitthaya P, Pimentel S, Talwalkar JA, Enders FT, Lindor KD, Krom RA, Wiesner RH.

    Liver Transpl. 2007 Sep;13(9):1236-45.PMID: 17763401 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Nonalcoholic fatty liver disease.

    Adams LA, Lindor KD.

    Ann Epidemiol. 2007 Nov;17(11):863-9. Epub 2007 Aug 28. Review.PMID: 17728149 [PubMed - indexed for MEDLINE]Related articles

    39.

    HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis.

    Nelson JE, Bhattacharya R, Lindor KD, Chalasani N, Raaka S, Heathcote EJ, Miskovsky E, Shaffer E, Rulyak SJ, Kowdley KV.

    Hepatology. 2007 Sep;46(3):723-9.PMID: 17680648 [PubMed - indexed for MEDLINE]Related articles

    40.

    Increased prevalence of antimitochondrial antibodies in first-degree relatives of patients with primary biliary cirrhosis.

    Lazaridis KN, Juran BD, Boe GM, Slusser JP, de Andrade M, Homburger HA, Ghosh K, Dickson ER, Lindor KD, Petersen GM.

    Hepatology. 2007 Sep;46(3):785-92.PMID: 17680647 [PubMed - indexed for MEDLINE]Related articles

    41.

    Risk of lymphoma in primary biliary cirrhosis.

    Panjala C, Talwalkar JA, Lindor KD.

    Clin Gastroenterol Hepatol. 2007 Jun;5(6):761-4.PMID: 17545001 [PubMed - indexed for MEDLINE]Related articles

    42.

    Role of radiologic modalities in the management of non-alcoholic steatohepatitis.

    Charatcharoenwitthaya P, Lindor KD.

    Clin Liver Dis. 2007 Feb;11(1):37-54, viii. Review.PMID: 17544971 [PubMed - indexed for MEDLINE]Related articles

    43.

    Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes.

    Silveira MG, Talwalkar JA, Angulo P, Lindor KD.

    Am J Gastroenterol. 2007 Jun;102(6):1244-50. Epub 2007 Feb 23.PMID: 17319931 [PubMed - indexed for MEDLINE]Related articles

    44.

    Open-label pilot study of folic acid in patients with nonalcoholic steatohepatitis.

    Charatcharoenwitthaya P, Levy C, Angulo P, Keach J, Jorgensen R, Lindor KD.

    Liver Int. 2007 Mar;27(2):220-6.PMID: 17311617 [PubMed - indexed for MEDLINE]Related articles

    45.

    Primary sclerosing cholangitis: patients with a rising alkaline phosphatase at annual follow-up.

    Charatcharoenwitthaya P, Lindor KD.

    Clin Gastroenterol Hepatol. 2007 Jan;5(1):32-6. No abstract available. PMID: 17234554 [PubMed - indexed for MEDLINE]Related articles

    46.

    Abnormal hepatic biochemistries in patients with inflammatory bowel disease.

    Mendes FD, Levy C, Enders FB, Loftus EV Jr, Angulo P, Lindor KD.

    Am J Gastroenterol. 2007 Feb;102(2):344-50. Epub 2006 Nov 13.PMID: 17100965 [PubMed - indexed for MEDLINE]Related articles

    47.

    Fluoxetine for the treatment of fatigue in primary biliary cirrhosis: a randomized, double-blind controlled trial.

    Talwalkar JA, Donlinger JJ, Gossard AA, Keach JC, Jorgensen RA, Petz JC, Lindor KD.

    Dig Dis Sci. 2006 Nov;51(11):1985-91. Epub 2006 Oct 20.PMID: 17053955 [PubMed - indexed for MEDLINE]Related articles

    48.

    Sclerosing cholangitis.

    Talwalkar JA, Lindor KD.

    Curr Opin Gastroenterol. 2002 May;18(3):372-7.PMID: 17033309 [PubMed]Related articles

    49.

    Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis.

    Mendes FD, Jorgensen R, Keach J, Katzmann JA, Smyrk T, Donlinger J, Chari S, Lindor KD.

    Am J Gastroenterol. 2006 Sep;101(9):2070-5. Epub 2006 Jul 27.PMID: 16879434 [PubMed - indexed for MEDLINE]Related articles

    50.

    Primary sclerosing cholangitis: diagnosis and management.

    Charatcharoenwitthaya P, Lindor KD.

    Curr Gastroenterol Rep. 2006 Feb;8(1):75-82. Review.PMID: 16510038 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...